Génomic Vision SA ROCE
Mi az Génomic Vision SA ROCE?
A ROCE az Génomic Vision SA - -270.17%
Mi a ROCE meghatározása?
A befektetett tőke megtérülése (ROCE) olyan pénzügyi arány, amely a vállalat jövedelmezőségét és a tőke felhasználásának hatékonyságát méri.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE a Health Care szektor a EURONEXT-on cégekben a Génomic Vision SA -hoz képest
Mit csinál Génomic Vision SA?
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
roce -hoz hasonló cégek Génomic Vision SA
- Wildcat Petroleum Plc nak ROCE -276.15% van
- Precigen Inc nak ROCE -274.10% van
- RJK Explorations nak ROCE -273.32% van
- Genocea Biosciences nak ROCE -272.40% van
- Salarius Pharmaceuticals nak ROCE -272.14% van
- BTC Digital nak ROCE -271.67% van
- Génomic Vision SA nak ROCE -270.17% van
- Tryp Therapeutics nak ROCE -269.74% van
- Burin Gold Corp nak ROCE -266.17% van
- Phimedix Plc nak ROCE -263.96% van
- Vivid Technology nak ROCE -263.70% van
- Pacific Empire Minerals nak ROCE -263.32% van
- Casper Sleep Inc nak ROCE -262.84% van